These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 15265244

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG.
    Eur J Med Res; 2004 Apr 30; 9(4):225-39. PubMed ID: 15210403
    [Abstract] [Full Text] [Related]

  • 5. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
    Hull RD, Pineo GF.
    Semin Thromb Hemost; 2004 Feb 30; 30 Suppl 1():11-23. PubMed ID: 15085462
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pulmonary embolism in medical patients: improved diagnosis and the role of low-molecular-weight heparin in prevention and treatment.
    Merli GJ.
    J Thromb Thrombolysis; 2004 Oct 30; 18(2):117-25. PubMed ID: 15789178
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P, Simioni P, Pagnan A.
    Minerva Cardioangiol; 2003 Aug 30; 51(4):361-71. PubMed ID: 12900718
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.
    Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H.
    Br J Surg; 2001 Jul 30; 88(7):913-30. PubMed ID: 11442521
    [Abstract] [Full Text] [Related]

  • 12. Initial treatment of venous thromboembolism.
    McRae SJ, Ginsberg JS.
    Circulation; 2004 Aug 31; 110(9 Suppl 1):I3-9. PubMed ID: 15339875
    [Abstract] [Full Text] [Related]

  • 13. The use of antithrombotic drugs in older people.
    Tufano A, Cerbone AM, Di Minno G.
    Minerva Med; 2002 Feb 31; 93(1):13-26. PubMed ID: 11850611
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.
    Clin Ther; 2007 Nov 31; 29(11):2395-405. PubMed ID: 18158080
    [Abstract] [Full Text] [Related]

  • 16. Low molecular weight heparins in the outpatient management of venous thromboembolism.
    Bick RL.
    Semin Thromb Hemost; 1999 Nov 31; 25 Suppl 3():97-9. PubMed ID: 10549723
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low molecular weight heparins in the long-term treatment of venous thromboembolism.
    Liapis CD, Daskalopoulos ME, Daskalopoulou SE.
    J Cardiovasc Surg (Torino); 2002 Aug 31; 43(4):495-500. PubMed ID: 12124561
    [Abstract] [Full Text] [Related]

  • 19. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J, Riess H, Büller HR, Brom J, Weidinger G, Huisman MV.
    Haematologica; 2003 Oct 31; 88(10):1157-62. PubMed ID: 14555312
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.